ELIQUIS (E.R. Squibb & Sons, L.L.C.)
Welcome to the PulseAid listing for the ELIQUIS drug offered from E.R. Squibb & Sons, L.L.C.. This Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | E.R. Squibb & Sons, L.L.C. |
| NON-PROPRIETARY NAME: | apixaban |
| SUBSTANCE NAME: | APIXABAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-12-28 |
| END MARKETING DATE: | 0000-00-00 |
ELIQUIS HUMAN PRESCRIPTION DRUG Details:
| Item Description | ELIQUIS from E.R. Squibb & Sons, L.L.C. |
| LABELER NAME: | E.R. Squibb & Sons, L.L.C. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5(mg/1) |
| START MARKETING DATE: | 2012-12-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0003-0893_85dab2fd-ac9a-4279-92e2-c1c9cf83ffb2 |
| PRODUCT NDC: | 0003-0893 |
| APPLICATION NUMBER: | NDA202155 |
Other APIXABAN Pharmaceutical Manufacturers / Labelers:
